Five Prime Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Five Prime Therapeutics, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include FIVEPRIME. The owner is based in South San Francisco, CA.
111 Oyster Point Boulevard
South San Francisco, CA 94080
Showing of trademarks Trademarks
Trademark Classifications
Five Prime Therapeutics, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Five Prime Therapeutics, Inc. have?
Five Prime Therapeutics, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 2 cancelled.
What trademark classes does Five Prime Therapeutics, Inc. file in?
Five Prime Therapeutics, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Five Prime Therapeutics, Inc.'s most well-known trademarks?
Five Prime Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as FIVEPRIME. These are among 1 currently registered trademark in the portfolio.
What is Five Prime Therapeutics, Inc.'s trademark registration success rate?
Five Prime Therapeutics, Inc. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.